Search Results - "von Frenckell, Rémy"

Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial by Sharif, Hanisah, Singh, Iesha, Kouser, Lubna, Mösges, Ralph, Bonny, Marie-Alix, Karamani, Angeliki, Parkin, Rebecca V., Bovy, Nicolas, Kishore, Uday, Robb, Abigail, Katotomichelakis, Michael, Holtappels, Gabriële, Derycke, Lara, Corazza, Francis, von Frenckell, Rémy, Wathelet, Nathalie, Duchateau, Jean, Legon, Thierry, Pirotton, Sabine, Durham, Stephen R., Bachert, Claus, Shamji, Mohamed H.

“…A 3-week short-course of adjuvant-free hydrolysates of Lolium perenne peptide (LPP) immunotherapy for rhinoconjunctivitis with or without asthma over 4…”
Get full text

Short Course of Lolium Perenne Peptides (LPP) Immunotherapy Induces IL-35+ T Regulatory Cells (iTr35) that Promote B Regulatory Cells (Bregs) and Blocking Antibodies by Singh, Iesha, Sharif, Hanisah, Kouser, Lubna, Karamani, Angeliki, Kishore, Uday, Holtappels, Gabriële, Derycke, Lara, von Frenckell, Rémy, Wathelet, Nathalie, Duchateau, Jean, Legon, Thierry, Pirotton, Sabine, Mosges, Ralph, Durham, Stephen R., Bachert, Claus, Shamji, Mohamed H.

“…Grass pollen-driven IL-10+ Treg cells and iTR35 cells were increased at V6(P =0.001;P<0.01) but not at V8 in LPP as compared to placebo-treated group. rhIL-35…”
Get full text

Short Course of Lolium Perenne Peptides (LPP) Immunotherapy Deletes Circulating IL-4+IL-21+ T follicular helper cells and Induces FoxP3+ T follicular regulatory cells: A Randomized Controlled Trial by Sharif, Hanisah, Karamani, Angeliki, Parkin, Rebecca, Kouser, Lubna, Singh, Iesha, Robb, Abigail, Holtappels, Gabriële, Derycke, Lara, Frenckell, Rémy von, Wathelet, Nathalie, Duchateau, Jean, Legon, Thierry, Pirotton, Sabine, Mosges, Ralph, Durham, Stephen R., Bachert, Claus, Shamji, Mohamed H.

“…Circulating allergen-driven CD4+CXCR5+PD-1+Tfh, IL-4+/IL-21+Tfh, FoxP3+Tfr, FoxP3+Treg cells and sIgE levels were enumerated before (V2), and after treatment…”
Get full text

Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients by ANSSEAU, M, VON FRENCKELL, R, MIREL, J, MEURICE, E, PARENT, M, COUZINIER, J.-P, DEMAREZ, J.-P, SERRE, C, MERTENS, C, DE WILDE, J, BOTTE, L, DEVOITILLE, J.-M, EVRARD, J.-L, DE NAYER, A, DARIMONT, P, DEJAIFFE, G

“…A multicenter study compared the antidepressant efficacy and the tolerance of two doses of milnacipran (50 mg and 100 mg/day) and amitriptyline (150 mg/day) in…”
Get full text

Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose method by Maquet, P, Dive, D, Salmon, E, Sadzot, B, Franco, G, Poirrier, R, von Frenckell, R, Franck, G

“…Using the [18F]fluorodeoxyglucose method and positron emission tomography, we studied cerebral glucose utilization during sleep and wakefulness in 11 young…”
Get more information

Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials by TRIMBLE, Edward L, ABRAMS, Jeffrey S, SEIBEL, Nita, SHANKAR, Lalitha, SWART, Ann Marie, THERASSE, Patrick, VIKRAM, Bhadrasain, VON FRENCKELL, Remy, FRIEDLANDER, Michael, FUJIWARA, Keiichi, KAPLAN, Richard S, MEUNIER, Francoise, MEYER, Ralph M, CALVO, Fabien, CAZAP, Eduardo, DEYE, James, EISENHAUER, Elizabeth, FITZGERALD, Thomas J, LACOMBE, Denis, PARMAR, Max

“…The need for international collaboration in cancer clinical trials has grown stronger as we have made progress both in cancer treatment and screening. We…”
Get full text

Dopaminergic function in panic disorder: comparison with major and minor depression by Pitchot, W, Ansseau, M, Gonzalez Moreno, A, Hansenne, M, von Frenckell, R

“…Several lines of evidence suggest that dopamine might be involved in anxiety states. In this study, we assessed the growth hormone (GH) response to apomorphine…”
Get more information

Compulsive personality as predictor of response to serotoninergic antidepressants by Ansseau, M, Troisfontaines, B, Papart, P, von Frenckell, R

Get full text

Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies by von Frenckell, R, Ansseau, M, Serre, C, Sutet, P

“…Milnacipran is a new potential antidepressant selected for its equipotent inhibition of noradrenaline and serotonin uptake and its lack of effect at any…”
Get more information

Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder by ANSSEAU, M, OLIE, J.-P, VON FRENCKELL, R, JOURDAIN, G, STEHLE, B, GUILLET, P

“…The anxiolytic activity and tolerance of four doses of suriclone (0.1, 0.2, 0.3 and 0.4 mg tid), diazepam (5 mg tid), and placebo were compared in six parallel…”
Get full text

Oral contraceptives and the dexamethasone suppression test by Ansseau, M, Leboulle, D, Sulon, J, von Frenckell, R, Legros, J J

“…Among other confounding factors, the influence of the intake of estrogen-containing oral contraceptives on the dexamethasone suppression test (DST) results has…”
Get more information

Relationship between alpha 2-adrenergic function and suicidal behavior in depressed patients by Pitchot, W, Ansseau, M, Gonzalez Moreno, A, Wauthy, J, Hansenne, M, von Frenckell, R

“…The current main neurochemical theories of the biological correlates of suicidal behavior involve serotonergic and, to a lesser extent, dopaminergic systems…”
Get more information

Controlled comparison of buspirone and oxazepam in generalized anxiety by Ansseau, M, Papart, P, Gérard, M A, von Frenckell, R, Franck, G

“…The anxiolytic activity, the tolerance, and the withdrawal symptoms of buspirone and oxazepam were compared in two groups of 14 and 12 outpatients,…”
Get more information

Controlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam by Ansseau, M, von Frenckell, R

“…The clinical activity and the tolerance of cloxazolam (4 mg/day), a new anxiolytic benzodiazepine, was compared to bromazepam (12 mg/day) in two parallel…”
Get more information

Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine by Ansseau, M, von Frenckell, R, Gérard, M A, Mertens, C, De Wilde, J, Botte, L, Devoitille, J M, Evrard, J L, De Nayer, A, Darimont, P

“…A multicenter controlled study was designed to test the hypothesis that a loading dose of an antidepressant could shorten the latency of its clinical efficacy…”
Get more information

Initial study of methylclonazepam in generalized anxiety disorder: evidence for greater power in the cross-over design by ANSSEAU, M, DOUMONT, A, THIRY, D, VON FRENCKELL, R, COLLARD, J

“…The anxiolytic activity of methylclonazepam was compared to lorazepam and placebo in a double-blind, randomized cross-over study, using a latin square design,…”
Get full text

Neuroendocrine evaluation of catecholaminergic neurotransmission in mania by Ansseau, M, von Frenckell, R, Cerfontaine, J L, Papart, P, Franck, G, Timsit-Berthier, M, Geenen, V, Legros, J J

“…Several lines of evidence suggest catecholamine overactivity (noradrenergic and/or dopaminergic) in mania. We studied the growth hormone (GH) response to…”
Get more information

Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life ― a comparison of single vs divided dosage schedules of prazepam by ANSSEAU, M, DOUMONT, A, VON FRENCKELL, R, COLLARD, J

“…The anxiolytic activity and tolerance of two dosage schedules of prazepam, a long plasma half-life benzodiazepine, were compared under double-blind conditions…”
Get full text

Psychopathological correlates of dopaminergic disturbances in major depression by Pitchot, W, Hansenne, M, Moreno, A G, von Frenckell, R, Ansseau, M

“…In a recent report, we confirmed the role of dopamine in the pathophysiology of depression by demonstrating a blunted response of growth hormone (GH) to…”
Get more information

Prediction of cortisol response to dexamethasone from age and basal cortisol in normal volunteers: a negative study by ANSSEAU, M, VON FRENCKELL, R, SIMON, C, SULON, J, DEMEY-PONSART, E, FRANCK, G

“…The dexamethasone suppression test (1 mg at 23 h and 4 P.M. blood collection) was performed in 22 normal subjects. In contrast to a previous study using 0.5 mg…”
Get full text